非小细胞肺癌抗血管生成药物的当前及未来策略 - Suppr

Current and future strategies for antiangiogenic agents in non-small-cell lung cancer.

Herbst Roy S

Clin Lung Cancer. 2008 Mar;9 Suppl 2:S50. doi: 10.3816/CLC.2008.s.007.

Abstract

摘要

Clin Lung Cancer. 2008 Mar;9 Suppl 2:S50. doi: 10.3816/CLC.2008.s.007.

Hematol Oncol Clin North Am. 2004 Oct;18(5):1121-41, ix. doi: 10.1016/j.hoc.2004.06.005.

Pneumonol Alergol Pol. 2006;74(4):414-20.

Expert Rev Anticancer Ther. 2011 Oct;11(10):1607-18. doi: 10.1586/era.11.146.

Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86. doi: 10.1517/13543780903336050.

Gan To Kagaku Ryoho. 2015 Aug;42(8):940-3.

Lung Cancer. 2010 Dec;70(3):233-46. doi: 10.1016/j.lungcan.2010.08.018.

Suppl Tumori. 2002 Jul-Aug;1(4):S39-43.

Curr Opin Oncol. 2008 Mar;20(2):176-82. doi: 10.1097/CCO.0b013e3282f4e55e.

Crit Rev Oncol Hematol. 2012 May;82(2):200-12. doi: 10.1016/j.critrevonc.2011.05.003. Epub 2011 Jun 28.

Thorac Cancer. 2018 Apr;9(4):445-451. doi: 10.1111/1759-7714.12603. Epub 2018 Feb 23.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。